Covered recipient · General Payments record
WILLIAM HANS GROS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$737.30
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.63 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $85.01 | 4 |
| PFIZER INC. | $51.39 | 2 |
| GlaxoSmithKline, LLC. | $29.74 | 1 |
| ABBVIE INC. | $28.60 | 1 |
| Acerta Pharma LLC | $28.11 | 1 |
| Janssen Pharmaceuticals, Inc | $24.76 | 1 |
| Lilly USA, LLC | $23.81 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.60 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103842224 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.11 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104516576 | CMS |
| GlaxoSmithKline, LLC. | $29.74 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116426431 | CMS |
| Janssen Pharmaceuticals, Inc | $24.76 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078009180 | CMS |
| Lilly USA, LLC | $23.81 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135480665 | CMS |
| Novo Nordisk Inc | $24.45 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097191908 | CMS |
| Novo Nordisk Inc | $18.53 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097383367 | CMS |
| Novo Nordisk Inc | $19.25 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096910731 | CMS |
| Novo Nordisk Inc | $22.78 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096618322 | CMS |
| PFIZER INC. | $25.75 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131388445 | CMS |
| PFIZER INC. | $25.64 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131320377 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.21 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151068075 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.